CN1816557A - 新型14和15元环化合物 - Google Patents

新型14和15元环化合物 Download PDF

Info

Publication number
CN1816557A
CN1816557A CNA2004800191978A CN200480019197A CN1816557A CN 1816557 A CN1816557 A CN 1816557A CN A2004800191978 A CNA2004800191978 A CN A2004800191978A CN 200480019197 A CN200480019197 A CN 200480019197A CN 1816557 A CN1816557 A CN 1816557A
Authority
CN
China
Prior art keywords
alkyl
hydrogen
optionally substituted
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800191978A
Other languages
English (en)
Chinese (zh)
Inventor
S·阿利霍兹克
R·L·亚维斯特
I·帕勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Fidelta doo
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Institut doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Institut doo filed Critical Glaxo Group Ltd
Publication of CN1816557A publication Critical patent/CN1816557A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24149—Honeycomb-like
    • Y10T428/24157—Filled honeycomb cells [e.g., solid substance in cavities, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CNA2004800191978A 2003-05-13 2004-05-11 新型14和15元环化合物 Pending CN1816557A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0310980.8 2003-05-13
GBGB0310980.8A GB0310980D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
CN1816557A true CN1816557A (zh) 2006-08-09

Family

ID=9957980

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800191978A Pending CN1816557A (zh) 2003-05-13 2004-05-11 新型14和15元环化合物

Country Status (11)

Country Link
US (1) US20070141276A1 (de)
EP (1) EP1628990B1 (de)
JP (1) JP2007500193A (de)
CN (1) CN1816557A (de)
AR (1) AR044306A1 (de)
AT (1) ATE450543T1 (de)
CA (1) CA2525457A1 (de)
CL (1) CL2004001006A1 (de)
DE (1) DE602004024388D1 (de)
GB (1) GB0310980D0 (de)
WO (1) WO2004101588A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104797588A (zh) * 2012-09-18 2015-07-22 赛诺菲 大环内酯衍生物、其制备及其治疗用途
CN114007625A (zh) * 2019-04-18 2022-02-01 阿祖拉眼科有限公司 用于治疗眼病的化合物和方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303854A1 (en) * 2003-12-11 2005-06-29 Airbus Sandwich panel core
WO2005108413A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O Carbamate linked macrolides useful for the treatment of microbial infections
JP2008540503A (ja) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
WO1990011288A1 (en) * 1989-03-28 1990-10-04 Abbott Laboratories Erythromycin derivatives
AU3710695A (en) * 1995-04-27 1996-11-18 Laboratorios Aranda, S.A. De C.V. Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
JP2002502366A (ja) * 1996-05-07 2002-01-22 アボット・ラボラトリーズ ３―デスクラジノース―２，３―無水エリスロマイシン誘導体
EP0895999A1 (de) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4"-substituierte Macrolidantibiotica
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 １１ａ−アザライド化合物及びその製造方法
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104797588A (zh) * 2012-09-18 2015-07-22 赛诺菲 大环内酯衍生物、其制备及其治疗用途
CN114007625A (zh) * 2019-04-18 2022-02-01 阿祖拉眼科有限公司 用于治疗眼病的化合物和方法

Also Published As

Publication number Publication date
EP1628990B1 (de) 2009-12-02
JP2007500193A (ja) 2007-01-11
EP1628990A1 (de) 2006-03-01
CL2004001006A1 (es) 2005-03-18
US20070141276A1 (en) 2007-06-21
GB0310980D0 (en) 2003-06-18
DE602004024388D1 (de) 2010-01-14
CA2525457A1 (en) 2004-11-25
WO2004101588A1 (en) 2004-11-25
ATE450543T1 (de) 2009-12-15
AR044306A1 (es) 2005-09-07

Similar Documents

Publication Publication Date Title
CN1088709C (zh) 胺类化合物及其酸加成盐
CN100335491C (zh) 具有抗炎活性的大环内酯化合物
CN1216064C (zh) 6－o－取代的红霉素衍生物的制备方法
CN1264837C (zh) 喹诺酮抗微生物剂、其组合物和应用
CN1273475C (zh) 具有抗细菌活性的6－0－取代的酮基内酯类化合物
CN1065069A (zh) 新的红霉素衍生物的制备方法
CN1241931C (zh) 大环内酯抗感染药物
CN1269833C (zh) 新的芳香酰胺、其制备方法以及作为药物的应用
CN1612888A (zh) 大环内酯类化合物
CN1659178A (zh) 6、11二环红霉素衍生物
CN1126997A (zh) 红霉素的新型衍生物，其制备方法及作为药物的应用
CN1072219C (zh) 二氮杂䓬酮、其生产和用途
CN1538967A (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1259135A (zh) 9－肟红霉素衍生物
CN1674898A (zh) 作为促旋酶和 /或拓扑异构酶 i v的抑制剂用于治疗细菌感染的 2 －脲基－6－杂芳基－3 h－苯并咪唑－4－羧酸衍生物和相关化合物
CN1240707C (zh) 2－卤代－6－0－取代的酮内酯衍生物
CN1151165C (zh) 具有抗炎活性的大环内酯
CN1096784A (zh) 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂
CN1048242C (zh) 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物
CN1271363A (zh) 具有抗菌活性的3’－n－修饰的6－o－取代的红霉素酮基内酯衍生物
CN1343215A (zh) 具有抗菌活性的6－o－取代大环内酯类化合物
CN1299356A (zh) 喹喏酮羧酸衍生物及其盐
CN101052633A (zh) 制备吲唑化合物的方法
CN1205704A (zh) 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物
CN1849328A (zh) 新型14和15元环化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20060809